Vivolta, a specialist in medical electrospinning solutions, has entered a long-term partnership with UK-based Neurochase to ...

Osivax, a biopharmaceutical company developing vaccines for broad-spectrum protection against infectious viruses, has ...

First patient dosed in phase 1b trial of MB310 therapy Microbiotica, a clinical-stage biopharma company, has announced the dosing of the first patient in its Phase 1b First-in-Human trial, COMPOSER-1, ...

The Scottish Medicines Consortium (SMC) has approved Kite’s CAR T-cell therapy, Yescarta (axi-cel), for treating adult patients with diffuse large B cell lymphoma (DLBCL) and high-grade B-cell ...

The Scottish Medicines Consortium (SMC) has recommended Yselty (linzagolix) for treating moderate to severe symptoms of uterine fibroids (UFs) in women of reproductive age. This decision means ...

Peace out When Bob Marley sang about ‘so much trouble in t ...